全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

查看量下载量

相关文章

更多...

PGRMC1 Elevation in Multiple Cancers and Essential Role in Stem Cell Survival

DOI: 10.4236/alc.2015.43006, PP. 37-51

Keywords: Lung Cancer, Oral Cancer, Head and Neck Cancer, Stem Cells, PGRMC1

Full-Text   Cite this paper   Add to My Lib

Abstract:

Cancer is one of the leading causes of death in America, and there is an urgent need for new therapeutic approaches. The progesterone receptor membrane component 1 (PGRMC1) is a cytochrome b5 related protein that binds heme and is associated with signaling, apoptotic suppression and autophagy. PGRMC1 is essential for tumor formation, invasion and metastasis, and is upregulated in breast, colon, lung and thyroid tumors. In the present study, we have analyzed PGRMC1 levels in over 600 tumor sections, including a larger cohort of lung tumors than in previous studies, and report the first clinical analysis of PGRMC1 levels in human oral cavity and ovarian tumors compared to corresponding nonmalignant tissues. PGRMC1 was highly expressed in lung and ovarian cancers and correlated with patient survival. PGRMC1 has been previously associated with drug resistance, a characteristic of cancer stem cells. The stem cell theory proposes that a subset of cancerous stem cells contribute to drug resistance and tumor maintenance, and PGRMC1 was detected in lung-tumor derived stem cells. Drug treatment with a PGRMC1 inhibitor, AG-205, triggered stem cell death whereas treatment with erlotinib and the ERK inhibitor, PD98059, did not, suggesting a specific role for PGRMC1 in cancer stem cell viability. Together, our data demonstrate PGRMC1 as a potential tumor biomarker across a variety of tumors, as well as a therapeutic target for cancer stem cells.

 References

[1]  Rohe, H.J., Ahmed, I.S., Twist, K.E. and Craven, R.J. (2009) PGRMC1 (Progesterone Receptor Membrane Component 1): A Targetable Protein with Multiple Functions in Steroid Signaling, P450 Activation and Drug Binding. Pharmacology & Therapeutics, 121, 14-19.
http://dx.doi.org/10.1016/j.pharmthera.2008.09.006
[2]  Mir, S.U., Ahmed, I.S., Arnold, S. and Craven, R.J. (2011) Elevated Pgrmc1 (Progesterone Receptor Membrane Component 1)/Sigma-2 Receptor Levels in Lung Tumors and Plasma from Lung Cancer Patients. International Journal of Cancer.
[3]  Chen, W.S., Chen, P.L., Li, J., Lind, A.C. and Lu, D. (2013) Lipid Synthesis and Processing Proteins ABHD5, PGRMC1 and Squalene Synthase Can Serve as Novel Immunohistochemical Markers for Sebaceous Neoplasms and Differentiate Sebaceous Carcinoma from Sebaceoma and Basal Cell Carcinoma with Clear Cell Features. Journal of Cutaneous Pathology, 40, 631-638.
http://dx.doi.org/10.1111/cup.12147
[4]  Ahmed, I.S., Rohe, H.J., Twist, K.E., Mattingly, M.N. and Craven, R.J. (2010) Progesterone Receptor Membrane Component 1 (Pgrmc1): A Heme-1 Domain Protein That Promotes Tumorigenesis and Is Inhibited by a Small Molecule. Journal of Pharmacology and Experimental Therapeutics, 333, 564-573.
http://dx.doi.org/10.1124/jpet.109.164210
[5]  Peluso, J.J., Gawkowska, A., Liu, X., Shioda, T. and Pru, J.K. (2009) Progesterone Receptor Membrane Component-1 Regulates the Development and Cisplatin Sensitivity of Human Ovarian Tumors in Athymic Nude Mice. Endocrinology, 150, 4846-4854.
http://dx.doi.org/10.1210/en.2009-0730
[6]  Peluso, J.J., Pappalardo, A., Losel, R. and Wehling, M. (2006) Progesterone Membrane Receptor Component 1 Expression in the Immature Rat Ovary and Its Role in Mediating Progesterone’s Antiapoptotic Action. Endocrinology, 147, 3133-3140.
http://dx.doi.org/10.1210/en.2006-0114
[7]  Friel, A.M., Zhang, L., Pru, C.A., Clark, N.C., McCallum, M.L., Blok, L.J., Shioda, T., Peluso, J.J., Rueda, B.R. and Pru, J.K. (2015) Progesterone Receptor Membrane Component 1 Deficiency Attenuates Growth While Promoting Chemosensitivity of Human Endometrial Xenograft Tumors. Cancer Letters, 356, 434-442.
http://dx.doi.org/10.1016/j.canlet.2014.09.036
[8]  Lin, S.T., May, E.W., Chang, J.F., Hu, R.Y., Wang, L.H. and Chan, H.L. (2015) PGRMC1 Contributes to Doxorubicin-Induced Chemoresistance in MES-SA Uterine Sarcoma. Cellular and Molecular Life Sciences: CMLS, 72, 2395-2409.
http://dx.doi.org/10.1007/s00018-014-1831-9
[9]  Lin, S.T., Chou, H.C., Chang, S.J., Chen, Y.W., Lyu, P.C., Wang, W.C., Chang, M.D. and Chan, H.L. (2012) Proteomic Analysis of Proteins Responsible for the Development of Doxorubicin Resistance in Human Uterine Cancer Cells. Journal of Proteomics, 75, 5822-5847.
http://dx.doi.org/10.1016/j.jprot.2012.07.047
[10]  Ahmed, I.S., Rohe, H.J., Twist, K.E. and Craven, R.J. (2010) Pgrmc1 (Progesterone Receptor Membrane Component 1) Associates with Epidermal Growth Factor Receptor and Regulates Erlotinib Sensitivity. Journal of Biological Chemistry, 285, 24775-24782.
http://dx.doi.org/10.1074/jbc.M110.134585
[11]  Aizen, J. and Thomas, P. (2015) Role of Pgrmc1 in Estrogen Maintenance of Meiotic Arrest in Zebrafish Oocytes through Gper/Egfr. The Journal of Endocrinology, 225, 59-68.
http://dx.doi.org/10.1530/JOE-14-0576
[12]  Mir, S.U., Jin, L. and Craven, R.J. (2012) Neutrophil Gelatinase-Associated Lipocalin (NGAL) Expression Dependent on the Tumor-Associated Sigma-2 Receptor S2RPgrmc1. The Journal of Biological Chemistry, 287, 14494-14501.
http://dx.doi.org/10.1074/jbc.M111.324921
[13]  Peluso, J.J., Liu, X., Gawkowska, A., Lodde, V. and Wu, C.A. (2010) Progesterone Inhibits Apoptosis in Part by PGRMC1-Regulated Gene Expression. Molecular and Cellular Endocrinology, 320, 153-161.
http://dx.doi.org/10.1016/j.mce.2010.02.005
[14]  Luciano, A.M., Lodde, V., Franciosi, F., Ceciliani, F. and Peluso, J.J. (2010) Progesterone Receptor Membrane Component 1 Expression and Putative Function in Bovine Oocyte Maturation, Fertilization, and Early Embryonic Development. Reproduction, 140, 663-672.
http://dx.doi.org/10.1530/REP-10-0218
[15]  Lodde, V. and Peluso, J.J. (2011) A Novel Role for Progesterone and Progesterone Receptor Membrane Component 1 in Regulating Spindle Microtubule Stability during Rat and Human Ovarian Cell Mitosis. Biology of Reproduction, 84, 715-722.
http://dx.doi.org/10.1095/biolreprod.110.088385
[16]  Zhang, M., Robitaille, M., Showalter, A.D., Huang, X., Liu, Y., Bhattacharjee, A., Willard, F.S., Han, J., Froese, S., Wei, L., et al. (2014) Progesterone Receptor Membrane Component 1 Is a Functional Part of the Glucagon-Like Peptide-1 (GLP-1) Receptor Complex in Pancreatic beta Cells. Molecular & Cellular Proteomics: MCP, 13, 3049-3062.
http://dx.doi.org/10.1074/mcp.M114.040196
[17]  Thomas, P., Pang, Y. and Dong, J. (2014) Enhancement of Cell Surface Expression and Receptor Functions of Membrane Progestin Receptor Alpha (mPRalpha) by Progesterone Receptor Membrane Component 1 (PGRMC1): Evidence for a Role of PGRMC1 as an Adaptor Protein for Steroid Receptors. Endocrinology, 155, 1107-1119.
http://dx.doi.org/10.1210/en.2013-1991
[18]  Falkenstein, E., Meyer, C., Eisen, C., Scriba, P.C. and Wehling, M. (1996) Full-Length cDNA Sequence of a Progesterone Membrane-Binding Protein from Porcine Vascular Smooth Muscle Cells. Biochemical and Biophysical Research Communications, 229, 86-89.
http://dx.doi.org/10.1006/bbrc.1996.1761
[19]  Meyer, C., Schmid, R., Scriba, P.C. and Wehling, M. (1996) Purification and Partial Sequencing of High-Affinity Progesterone-Binding Site(s) from Porcine Liver Membranes. European Journal of Biochemistry, 239, 726-731.
http://dx.doi.org/10.1111/j.1432-1033.1996.0726u.x
[20]  Gerdes, D., Wehling, M., Leube, B. and Falkenstein, E. (1998) Cloning and Tissue Expression of Two Putative Steroid Membrane Receptors. Biological Chemistry, 379, 907-911.
[21]  Peluso, J.J., Liu, X., Gawkowska, A. and Johnston-MacAnanny, E. (2009) Progesterone Activates a Progesterone Receptor Membrane Component 1-Dependent Mechanism That Promotes Human Granulosa/Luteal Cell Survival but Not Progesterone Secretion. Journal of Clinical Endocrinology & Metabolism, 94, 2644-2649.
http://dx.doi.org/10.1210/jc.2009-0147
[22]  Peluso, J.J., Romak, J. and Liu, X. (2008) Progesterone Receptor Membrane Component-1 (PGRMC1) Is the Mediator of Progesterone’s Antiapoptotic Action in Spontaneously Immortalized Granulosa Cells as Revealed by PGRMC1 Small Interfering Ribonucleic Acid Treatment and Functional Analysis of PGRMC1 Mutations. Endocrinology, 149, 534-543.
http://dx.doi.org/10.1210/en.2007-1050
[23]  Kaluka, D., Batabyal, D., Chiang, B.Y., Poulos, T.L. and Yeh, S.R. (2015) Spectroscopic and Mutagenesis Studies of Human PGRMC1. Biochemistry, 54, 1638-1647.
http://dx.doi.org/10.1021/bi501177e
[24]  Liu, L., Wang, J., Zhao, L., Nilsen, J., McClure, K., Wong, K. and Brinton, R.D. (2009) Progesterone Increases Rat Neural Progenitor Cell Cycle Gene Expression and Proliferation via Extracellularly Regulated Kinase and Progesterone Receptor Membrane Components 1 and 2. Endocrinology, 150, 3186-3196.
http://dx.doi.org/10.1210/en.2008-1447
[25]  Brisken, C. (2013) Progesterone Signalling in Breast Cancer: A Neglected Hormone Coming into the Limelight. Nature Reviews Cancer, 13, 385-396.
http://dx.doi.org/10.1038/nrc3518
[26]  Mifsud, W. and Bateman, A. (2002) Membrane-Bound Progesterone Receptors Contain a Cytochrome b5-Like Ligand-Binding Domain. Genome Biology, 3, RESEARCH0068.
[27]  Crudden, G., Chitti, R.E. and Craven, R.J. (2006) Hpr6 (Heme-1 Domain Protein) Regulates the Susceptibility of Cancer Cells to Chemotherapeutic Drugs. Journal of Pharmacology and Experimental Therapeutics, 316, 448-455.
http://dx.doi.org/10.1124/jpet.105.094631
[28]  Mallory, J.C., Crudden, G., Johnson, B.L., Mo, C., Pierson, C.A., Bard, M. and Craven, R.J. (2005) Dap1p, a Heme-Binding Protein That Regulates the Cytochrome P450 Protein Erg11p/Cyp51p in Saccharomyces cerevisiae. Molecular and Cellular Biology, 25, 1669-1679.
http://dx.doi.org/10.1128/MCB.25.5.1669-1679.2005
[29]  Min, L., Takemori, H., Nonaka, Y., Katoh, Y., Doi, J., Horike, N., Osamu, H., Raza, F.S., Vinson, G.P. and Okamoto, M. (2004) Characterization of the Adrenal-Specific Antigen IZA (Inner Zone Antigen) and Its Role in the Steroidogenesis. Molecular and Cellular Endocrinology, 215, 143-148.
http://dx.doi.org/10.1016/j.mce.2003.11.025
[30]  Min, L., Strushkevich, N.V., Harnastai, I.N., Iwamoto, H., Gilep, A.A., Takemori, H., Usanov, S.A., Nonaka, Y., Hori, H., Vinson, G.P., et al. (2005) Molecular Identification of Adrenal Inner Zone Antigen as a Heme-Binding Protein. FEBS Journal, 272, 5832-5843.
http://dx.doi.org/10.1111/j.1742-4658.2005.04977.x
[31]  Debose-Boyd, R.A. (2007) A Helping Hand for Cytochrome p450 Enzymes. Cell Metabolism, 5, 81-83.
http://dx.doi.org/10.1016/j.cmet.2007.01.007
[32]  Hughes, A.L., Powell, D.W., Bard, M., Eckstein, J., Barbuch, R., Link, A.J. and Espenshade, P.J. (2007) Dap1/ PGRMC1 Binds and Regulates Cytochrome P450 Enzymes. Cell Metabolism, 5, 143-149.
http://dx.doi.org/10.1016/j.cmet.2006.12.009
[33]  Thompson, A.M., Reddi, A.R., Shi, X., Goldbeck, R.A., Moenne-Loccoz, P., Gibney, B.R. and Holman, T.R. (2007) Measurement of the Heme Affinity for Yeast Dap1p, and Its Importance in Cellular Function. Biochemistry, 46, 14629-14637.
[34]  Mallory, J. and Craven, R. (2011) Candida albicans Dap1p Promotes Ergosterol Synthesis via the P450 Protein Erg11p/Cyp51p, Regulating Susceptibility to Azole Antifungal Drugs, Morphogenesis and Damage Resistance. Pharmacologia, 3, 179-189.
[35]  Jordan, C.T., Guzman, M.L. and Noble, M. (2006) Cancer Stem Cells. The New England Journal of Medicine, 355, 1253-1261.
http://dx.doi.org/10.1056/NEJMra061808
[36]  Singh, A. and Settleman, J. (2010) EMT, Cancer Stem Cells and Drug Resistance: An Emerging Axis of Evil in the War on Cancer. Oncogene, 29, 4741-4751.
http://dx.doi.org/10.1038/onc.2010.215
[37]  Corradetti, B., Correani, A., Romaldini, A., Marini, M.G., Bizzaro, D., Perrini, C., Cremonesi, F. and Lange-Consiglio, A. (2014) Amniotic Membrane-Derived Mesenchymal Cells and Their Conditioned Media: Potential Candidates for Uterine Regenerative Therapy in the Horse. PLoS ONE, 9, e111324.
http://dx.doi.org/10.1371/journal.pone.0111324
[38]  Mathis, S.E., Alberico, A., Nande, R., Neto, W., Lawrence, L., McCallister, D.R., Denvir, J., Kimmey, G.A., Mogul, M., Oakley, G., et al. (2014) Chemo-Predictive Assay for Targeting Cancer Stem-Like Cells in Patients Affected by Brain Tumors. PLoS ONE, 9, e105710.
http://dx.doi.org/10.1371/journal.pone.0105710
[39]  Maiuri, M.C., Zalckvar, E., Kimchi, A. and Kroemer, G. (2007) Self-Eating and Self-Killing: Crosstalk between Autophagy and Apoptosis. Nature Reviews Molecular Cell Biology, 8, 741-752.
http://dx.doi.org/10.1038/nrm2239
[40]  Mir, S.U., Schwarze, S., Jin, L., Zhang, J., Friend, W., Miriyala, S., St Clair, D. and Craven, R.J. (2013) Progesterone Receptor Membrane Component 1/Sigma-2 Receptor Associates with MAP1LC3B and Promotes Autophagy. Autophagy, 9, 1566-1578.
http://dx.doi.org/10.4161/auto.25889
[41]  Levine, B. and Kroemer, G. (2008) Autophagy in the Pathogenesis of Disease. Cell, 132, 27-42.
http://dx.doi.org/10.1016/j.cell.2007.12.018
[42]  Peluso, J.J. (2007) Non-Genomic Actions of Progesterone in the Normal and Neoplastic Mammalian Ovary. Seminars in Reproductive Medicine, 25, 198-207.
http://dx.doi.org/10.1055/s-2007-973432
[43]  Peluso, J.J. (2011) Progesterone Signaling Mediated through Progesterone Receptor Membrane Component-1 in Ovarian Cells with Special Emphasis on Ovarian Cancer. Steroids, 76, 903-909.
http://dx.doi.org/10.1016/j.steroids.2011.02.011
[44]  Panda, H., Chuang, T.D., Luo, X. and Chegini, N. (2012) Endometrial miR-181a and miR-98 Expression Is Altered during Transition from Normal into Cancerous State and Target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3. Journal of Clinical Endocrinology & Metabolism, 97, E1316-E1326.
http://dx.doi.org/10.1210/jc.2012-1018
[45]  Albrecht, C., Huck, V., Wehling, M. and Wendler, A. (2012) In Vitro Inhibition of SKOV-3 Cell Migration as a Distinctive Feature of Progesterone Receptor Membrane Component Type 2 versus Type 1. Steroids, 77, 1543-1550.
http://dx.doi.org/10.1016/j.steroids.2012.09.006
[46]  Peluso, J.J. and Pru, J.K. (2014) Non-Canonical Progesterone Signaling in Granulosa Cell Function. Reproduction, 147, R169-R178.
http://dx.doi.org/10.1530/rep-13-0582
[47]  Elassar, A., Liu, X., Scranton, V., Wu, C.A. and Peluso, J.J. (2012) The Relationship between Follicle Development and Progesterone Receptor Membrane Component-1 Expression in Women Undergoing in Vitro Fertilization. Fertility and Sterility, 97, 572-578.
http://dx.doi.org/10.1016/j.fertnstert.2011.12.026
[48]  Mansouri, M.R., Schuster, J., Badhai, J., Stattin, E.L., Losel, R., Wehling, M., Carlsson, B., Hovatta, O., Karlstrom, P.O., Golovleva, I., et al. (2008) Alterations in the Expression, Structure and Function of Progesterone Receptor Membrane Component-1 (PGRMC1) in Premature Ovarian Failure. Human Molecular Genetics, 17, 3776-3783.
http://dx.doi.org/10.1093/hmg/ddn274
[49]  Spitzer, D., Simon Jr., P.O., Kashiwagi, H., Xu, J., Zeng, C., Vangveravong, S., Zhou, D., Chang, K., McDunn, J.E., Hornick, J.R., et al. (2012) Use of Multifunctional Sigma2 Receptor Ligand Conjugates to Trigger Cancer-Selective Cell Death Signaling. Cancer Research, 72, 201-209.
http://dx.doi.org/10.1158/0008-5472.CAN-11-1354
[50]  Perregaard, J., Moltzen, E.K., Meier, E. and Sanchez, C. (1995) Sigma Ligands with Subnanomolar Affinity and Preference for the Sigma2 Binding Site. 1. 3-(Omega-Aminoalkyl)-1H-Indoles. Journal of Medicinal Chemistry, 38, 1998-2008.
http://dx.doi.org/10.1021/jm00011a019
[51]  Ghelardini, C., Galeotti, N. and Bartolini, A. (2000) Pharmacological Identification of SM-21, the Novel Sigma2 Antagonist. Pharmacology, Biochemistry, and Behavior, 67, 659-662.
http://dx.doi.org/10.1016/S0091-3057(00)00405-6
[52]  Bowen, W.D., Bertha, C.M., Vilner, B.J. and Rice, K.C. (1995) CB-64D and CB-184: Ligands with High Sigma2 Receptor Affinity and Subtype Selectivity. European Journal of Pharmacology, 278, 257-260.
http://dx.doi.org/10.1016/0014-2999(95)00176-L
[53]  Xu, J., Zeng, C., Chu, W., Pan, F., Rothfuss, J.M., Zhang, F., Tu, Z., Zhou, D., Zeng, D., Vangveravong, S., et al. (2011) Identification of the PGRMC1 Protein Complex as the Putative Sigma2 Receptor Binding Site. Nature Communications, 2, 380.
http://dx.doi.org/10.1038/ncomms1386
[54]  Abate, C., Niso, M., Infantino, V., Menga, A. and Berardi, F. (2015) Elements in Support of the “Non-Identity” of the PGRMC1 Protein with the Sigma2 Receptor. European Journal of Pharmacology, 758, 16-23.
http://dx.doi.org/10.1016/j.ejphar.2015.03.067

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133